5308032026-04-012026-06-305308032026-06-305308032026-04-012026-06-30in-capmkt:OtherExpenses1Member5308032026-04-012026-06-30in-capmkt:ReportableSegments1Member5308032026-04-012026-06-30in-capmkt:ReportableSegments2Member5308032026-04-012026-06-30in-capmkt:ReportableSegments3Member5308032026-04-012026-06-30in-capmkt:ReportableSegments4Member5308032026-04-012026-06-30in-capmkt:ReportableSegments1Member5308032026-04-012026-06-30in-capmkt:ReportableSegments2Member5308032026-04-012026-06-30in-capmkt:ReportableSegments3Member5308032026-04-012026-06-30in-capmkt:ReportableSegments4Member5308032026-04-012026-06-30in-capmkt:ReportableSegments1Member5308032026-06-30in-capmkt:ReportableSegments1Member5308032026-04-012026-06-30in-capmkt:ReportableSegments2Member5308032026-06-30in-capmkt:ReportableSegments2Member5308032026-04-012026-06-30in-capmkt:ReportableSegments3Member5308032026-06-30in-capmkt:ReportableSegments3Member5308032026-04-012026-06-30in-capmkt:ReportableSegments4Member5308032026-06-30in-capmkt:ReportableSegments4Member5308032026-04-012026-06-30in-capmkt:ReportableSegments1Member5308032026-06-30in-capmkt:ReportableSegments1Member5308032026-04-012026-06-30in-capmkt:ReportableSegments2Member5308032026-06-30in-capmkt:ReportableSegments2Member5308032026-04-012026-06-30in-capmkt:ReportableSegments3Member5308032026-06-30in-capmkt:ReportableSegments3Member5308032026-04-012026-06-30in-capmkt:ReportableSegments4Member5308032026-06-30in-capmkt:ReportableSegments4Member5308032026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15308032026-04-012026-06-30ItemsThatWillBeReclassifiedToProfitAndLoss15308032026-04-012026-06-30AuditorDomain1iso4217:INRiso4217:INRxbrli:shares530803BHAGERIANAINE354C01027BHAGERIA INDUSTRIES LIMITEDMain BoardEquity2026-04-012027-03-312026-07-222026-07-16INRLakhsQuarterlyFirst quarterMulti segment2026-07-2205:00:002026-07-2206:00:00Declaration of unmodified opinion2026-04-012026-06-30UnauditedConsolidated286418200015610700030202890002027965000316116000-2786520007091900019026000964390003075140002559327000460962000046096200012174400010800012185200003391100000000339110000900000340010000341518000-2408000342418000-240800021822100057.837.83007.837.83Notes on financial results :- <br /> 1 The Unaudited Consolidated Financial Result for the quarter ended June 30, 2026 have been reviewed by the Audit Committee and subsequently approved by the Board of Directors at the meeting held on July 22, 2026. The Statutory Auditors of the Company have carried out "Limited Review" of the above results as per Regulatlon 33 of the SEBI [Listing Obligation and Disclosure Requirements] Regulations, 2015. <br /> 2 The figures for the quarters ended on March 31, 2026 are the balancing figures between audited figures for the full financial year and published year to date figures up to the third quarter of the respective financial year. <br /> 3 Corresponding figures of previous year / quarter have been re-grouped/re-arranged, where considered necessary, to correspond to current year / quarter. <br /> 4 "In accordance with Ind AS 108 – Operating Segments, the Company has identified the following reportable segments : <br /> (a) Chemicals, which include Organic Chemicals and Inorganic Chemicals; (b) Solar Power, encompassing the Generation and Distribution of Solar Power; and (c) Pharma and (d) Others." <br /> 5 The full financial results are also available on the stock exchanges' website i.e. www.bseindia.com and www.nseindia.com and on the Company's website i.e. www.bhageriagroup.com. <br /> Other expenses307514000Segment -A (Chemical)2741747000Segment -B (Solar Power)108539000Segment -C (Pharma)5443000Others8461000286419000080002864182000Segment -A (Chemical)375172000Segment -B (Solar Power)52054000Segment -C (Pharma)-12928000Others433900041863700019026000-61351000460962000Segment -A (Chemical)6149944000Segment -B (Solar Power)2633020000Segment -C (Pharma)166632000Others15681500091064110005769840009683395000Segment -A (Chemical)1447828000Segment -B (Solar Power)1160685000Segment -C (Pharma)176458000Others11481700028997880005076680003407456000Remeasurement of the defined benefit plans943000943000238000Exchange differences on translation of foreign operations1950001950000900000UnauditedtrueSarada & Pareek LLPtrue2028-12-31